Breakthrough findings by Haruko Obokata and colleagues at the RIKEN Center for Developmental Biology (CDB) may upset the canonical views on the fundamental definitions of cellular differentiation and pluripotency. In a pair of reports in Nature, Obokata shows that ordinary somatic cells from newborn mice can be stripped of their differentiation memory, reverting to a state of pluripotency in many ways resembling that seen in embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs).
The conversion process, which Obokata has named STAP (stimulus-triggered acquisition of pluripotency), requires only that the cells be shocked with a dose of sublethal stress, such as low pH or mechanical force, in order to trigger a remarkable transformation, in which the cells shrink, lose the functional characteristics specific to their somatic cell type, and enter a state of stem cell-like pluripotency. Such STAP cells show all the hallmarks of pluripotency, and contribute to chimeric mice and germline transmission when injected into early stage embryos.
Even more interestingly, STAP cells show a level of plasticity that exceeds that even of ESCs and iPSCs, in that they can give rise to cells of both embryonic and extraembryonic lineages; other pluripotent stem cells typically only generate embryonic lineage cells. STAP cells also differ from stem cells in their lower ability to proliferate in culture, but Obokata found that by adding different factors to STAP culture medium, she was able to cause them to transform into either ‘STAP stem cells,’ which behaved very much like embryonic stem cells, or a second form of stem cell capable of both generating extra-embryonic lineages and long-term culture.
“It’s exciting to think about the new possibilities these findings open up, not only in areas like regenerative medicine, but perhaps in the study of cellular senescence and cancer as well,” says Obokata. “But the greatest challenge for me going forward will be to dig deeper into the underlying mechanisms, so that we can gain a deeper understanding of how differentiated cells can convert to such an extraordinarily pluripotent state.”
This work was done in collaboration with Charles Vacanti’s lab at Brigham and Women’s Hospital, Harvard University, Masayuki Yamato’s lab at Tokyo Women’s Medical University, and the laboratories for Genomic Reprogramming, Pluripotent Stem Cell Studies, and Organogenesis and Neurogenesis at the RIKEN CDB.
The research is reported in the following papers:
Bidirectional developmental potential in reprogrammed cells with acquired pluripotency
Stimulus-triggered fate conversion of somatic cells into pluripotency
Source: RIKEN
